A B S T R A C T We used ultrastructural morphometric methods to study the in vivo regulation of secretion in bronchiolar Clara cells of rats. The Clara cells studied were located in airways with an internal diameter of 0.21±0.06 mm (mean+SD) at a transpulmonary pressure of 20 cm H20. We found that pilocarpine caused a 50% decrease in the volume density of secretory granules of Clara cells in 60 min and that atropine blocked this effect. Isoproterenol produced a similar fall in volume density and this was blocked by propranolol. Propranolol also blocked the effect of pilocarpine. The fall in volume density of the secretory granules produced by pilocarpine and by isoproterenol occurred without any change in the surface-to-volume ratio of the granules. This indicates the change in volume density reflected a decrease in number rather than in size of the secretory granules. The observation that propranolol blocks the secretory response to pilocarpine as well as the response to isoproterenol suggests a dual in series cholinergic adrenergic regulation of secretion in bronchiolar Clara cells in rats.
A B S T R A C T We used ultrastructural morphometric methods to study the in vivo regulation of secretion in bronchiolar Clara cells of rats. The Clara cells studied were located in airways with an internal diameter of 0.21±0.06 mm (mean+SD) at a transpulmonary pressure of 20 cm H20. We found that pilocarpine caused a 50% decrease in the volume density of secretory granules of Clara cells in 60 min and that atropine blocked this effect. Isoproterenol produced a similar fall in volume density and this was blocked by propranolol. Propranolol also blocked the effect of pilocarpine. The fall in volume density of the secretory granules produced by pilocarpine and by isoproterenol occurred without any change in the surface-to-volume ratio of the granules. This indicates the change in volume density reflected a decrease in number rather than in size of the secretory granules. The observation that propranolol blocks the secretory response to pilocarpine as well as the response to isoproterenol suggests a dual in series cholinergic adrenergic regulation of secretion in bronchiolar Clara cells in rats.
INTRODUCTION
Clara cells are epithelial cells located mainly within distal conducting airways (1) (2) (3) . Although they are thought to secrete components of the extracellular lining layer of these airways (1), little is known about the nature of the secretory products, about the function of these products, or about the neurohumoral regulation of secretion in these cells. This lack of information may be particularly unfortunate because Clara cells are located mainly in small airways which are thought to be the sites of initial damage and dysfunc- tion in the most prevalent forms of chronic pulmonary disease in humans.
Study of the Clara cell has been seriously hampered because they have not been successfully isolated by cell separation or tissue culture techniques, and because their secretory products have not been identified and characterized. These considerations led to this study in which we have used ultrastructural morphometric methods to examine aspects ofthe in vivo neurohumoral regulation of secretion by Clara cells of rats.
METHODS
Animals. We used male Long Evans rats (Charles River Breeding Laboratories, Inc., Wilmington, Mass.). These were maintained by us on a 12-h light dark cycle and allowed food (Wayne Lab-Blox, Allied Mills, Inc., Chicago, Ill.) and water ad libitum until sacrificed.
Experimental procedures. The secretory agonists and antagonists were injected intraperitoneally into unanesthetized rats. We used pilocarpine (150 mg/kg body wt), atropine (14 mg/kg), isoproterenol (10 mg/kg), and propranolol (2.0 mg/ kg). These were given in 0.15 M NaCl; control rats received an equal volume of NaCl alone.
At specified times the rats were anesthetized by the intraperitoneal injection of pentobarbital sodium (30 mg/kg). The trachea was cannulated through a midline cervical incision while the animals were still breathing. A bilateral pneumothorax was produced by puncturing the diaphragm from its abdominal surface. We then infused 2.5% cold glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, into the trachea at a transpulmonary pressure of 20 cm H20. The trachea was ligated, the lungs removed from the thoracic cavity, and fixation was continued by placing the lungs in fixative for 2 (6, 7) . A multipurpose test system (6) 17.6 x 17.6 cm having 168 test points 1.5 cm apart was used to estimate the volume density and the surface-to-volume ratio of secretory granules. For calculation of volume density we counted enough test points in each animal to attain a relative error in each instance of <5% (6) . The volume density and surface-to-volume ratio of the secretory granules were calculated by standard methods (6) . Identification of Clara cells. In the conducting airways that had been measured by light microscopy, Clara cells were identified by electron microscopy as nonciliated cells abutting on, and frequently protruding into, the airway lumen. Most had one or more secretory granules and all had microvilli.
An example of what was considered to be a Clara cell is shown in Fig. 1 .
Statistical analysis. For each of the parameters measured or calculated from these measurements, the values for individual animal were averaged per experimental group and the standard error of the group mean calculated. The significance of differences between groups was calculated by an unpaired t test analysis (8) .
RESULTS
Effects of pilocarpine and atropine. The timecourse of the effect of pilocarpine on the volume density ofsecretory granules was examined. We found a fall of -25% in the volume density of the secretory granules within 30 min and -50% within 60 min after administering pilocarpine (Fig. 2) . Within 2 h after giving pilocarpine, the volume density of the secretory granules had returned to control levels. Atropine blocked the fall in the volume density of the secretory granules brought about by pilocarpine (Fig. 3) .
We also examined the effect of pilocarpine and atropine on the volume fraction of the secretory granules by relating the number of test probe points falling on the secretory granules to the fixed number of points on the test system. This showed that the volume (*) Indicates P <0.01 compared to the pilocarpine alone. All animals sacrificed 1 h after injection.
density of the secretory granules determined in this manner also fell after the administration of pilocarpine, and that this fall too was blocked by atropine (Table  I) . The surface-to-volume ratio ofthe secretory granules was not changed by pilocarpine or by pilocarpine plus atropine (Table II) . Effects of isoproterenol. Isoproterenol produced a fall in the volume density of Clara cell secretory granules equal to that produced by pilocarpine, and this effect was blocked by propranolol (Fig. 4) . The secretory granule volume density relative to the fixed number of points of the test system also fell after isoproterenol; propranolol blocked this effect (Table III) . These two agents did not alter the surface-to-volume ratio of the secretory granules (Table IV) .
Effect ofpropranolol on the response to pilocarpine. The secretory response to both pilocarpine and isoproterenol suggests possible dual cholinergic-adrenergic control of secretion in the Clara cells. This dual control might be in series or in parallel. We therefore examined the effect of propranolol on the secretory response to pilocarpine; propranolol completely blocked the fall in volume density of the secretory The animals were killed 1 h after injecting the diluent or the pharmacological agent. Values are mean+--SE, n = 3 in each instance. we have limited our examination to Clara cells located in airways with an internal diameter <0.4 mm at a transpulmonary pressure of 20 cm H20. This limitation was applied to more sharply define the location of the cells compared to the less clearly defined "small airway," and because of the possibility that cells at different levels of the conducting airways may be under different neurohumoral regulation. We have used a morphometric ultrastructural evaluation of inclusion bodies in Clara cells to assess secretion. The choice of this technique was dictated by the absence of methods to isolate these cells in pure form and by the lack of characterized secretory products. Our analysis rests on the assumption that these cells are indeed secretory cells and that changes in the volume density of these inclusions are because of secretion. The former assumption seems relatively secure because of the vast literature describing the ultrastructural characteristics of cells which make and store proteins destined to be secreted (10, 11) . These reports (Fig. 1) . We have considered the following possibilities in interpreting the changes in volume density of the secretory granules in response to pilocarpine and to isoproterenol. First, changes in the volume fraction relative to the cell could reflect differences in the cell volume, rather than a fall in the volume of secretory granules. We think that our studies relating the volume fraction of the secretory granules to the fixed number of points on the test system excludes changes in cell volume as the cause of the decrease in the volume density of the secretory granules.
Regulation of Secretion of Bronchiolar Clara Cells
A second possibility considered is that changes in the volume density of secretory granules could represent decreased synthesis of secretory products in the face of an unchanged rate ofsecretion, rather than an increased rate of secretion. We have not excluded this possibility and, in fact, cannot with the presently available technology. However, to our knowledge, there are no examples in the literature to support the notion that such a substantial reduction in intracellular secretory material after the administration of secretogogues is a result of alterations in synthesis rather than increased secretion.
Finally, considering the effect of pilocarpine and of isoproterenol on the volume density and surface-tovolume ratio sheds some light on the cellular events that follow the administration of these agents. A decrease in the size of an organelle will increase the surface-to-volume ratio. Our failure to find a change in this ratio after the administration of pilocarpine or of isoproterenol, coupled with the fall in volume fraction, indicates that the latter is a result of a decrease in the number of secretory granules, rather than a change in their size. Although this does not argue against a decrease in synthesis it is what one would expect in a secretory process.
Our studies showed that pilocarpine lowered the volume density of secretory granules and that this could be blocked by atropine. This is consistent with cholinergic-mediated secretion where pilocarpine mimicked the effect of postganglionic parasympathetic stimulation of Clara cells. The fall in the volume density of secretory granules after the administration of isoproterenol and the blocking of this effect by propranolol is consistent with f3-adrenergic involvement in secretion by Clara cells ofthe rat. It is theoretically possible that the cholinergic and adrenergic effect are mediated in parallel or in series. The blockade of the secretory effect of pilocarpine by propranolol, a ,3-adrenergic blocker, suggests, but does not prove (12) an in series cholinergic adrenergic regulation of secretion in the Clara cell.
Burn and Rand (13) first proposed a cholinergic component in adrenergic transmission to explain the finding that in several organs acetylcholine exerts action similar to that of sympathetic stimulation. This action was nicotinic rather than muscarinic in nature because it may be seen in the presence of atropine and is also produced by nicotine. Subsequently, Lloyd (14) reported studies on sweat glands in which he found evidence for dual control of sweating by cholinergic and adrenergic agents; the effect of both could be completely eliminated by adrenergic blockade, and the effect ofcholinergic agents could be blocked by atropine. This led Lloyd (14) to conclude that the duality of cholinergic and adrenergic regulation of secretion in the sweat gland was mediated in series with acetylcholine acting prejunctionally and noradrenaline postjunctionally. Our findings in the Clara cell are similar to those of Lloyd for sweat glands and may be subjected to the same interpretation, but with the same limitations (12) .
Because our studies were performed in vivo, the anatomical site of any proposed in series cholinergic adrenergic regulation ofsecretion remains unclear. It is possible that pilocarpine stimulated the adrenal gland to release sympathomimetic agents (15) and that the latter acted upon the Clara cell. A second consideration is that the cholinergic action might be on the central nervous system whose stimulation might evoke a secondary adrenergic stimulation (16) . Finally, both cholinergic and adrenergic mechanisms, in series or not, may be mediated by intrapulmonary nerves.
One additional area requires comment. Yoneda (17) recently reported that pilocarpine increases the volume density of secretory granules in the Clara cells of rats. This finding is clearly at odds with the effect of pilocarpine we are reporting, and we cannot explain this difference. Both studies used the same dose of pilocarpine, although administered by different routes, and the same species but different strains. However, Yoneda (17) fasted the rats that received pilocarpine and his control rats were either fasted or fed; all our rats were fed ad libitum. We are unaware of any studies showing an increase in secretory granules after administration of a cholinergic agent that occurs so rapidly, i.e., within 30 min and without an initial release of secretory product.
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